Beta Bionics (NASDAQ: BBNX) revenue
Beta Bionics reported revenue of $100.3m for fiscal 2025, 53.9% more than in fiscal 2024 ($65.1m). Since fiscal 2023 its revenue has grown by 735.8%, an average growth of 189.1% a year.
Beta Bionics has grown its revenue for 2 years in a row, and fiscal 2025 is the highest of its 3 fiscal years on record.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $100.3m | +53.9% | −$71.7m | −71.5% |
| 2024 | $65.1m | +442.9% | −$45.3m | −69.5% |
| 2023 | $12.0m | — | −$35.9m | −298.9% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Beta Bionics revenue compared with its sector
By revenue for its latest fiscal year, Beta Bionics ranks 286th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Beta Bionics, 53.9%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 284th | Sanara Medtech | $103.1m | 19.0% |
| 285th | Sutro Biopharma | $102.5m | 65.2% |
| 286th | Beta Bionics | $100.3m | 53.9% |
| 287th | Neuropace | $100.0m | 25.1% |
| 288th | Butterfly Network | $97.6m | 19.0% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Beta Bionics
- How much revenue did Beta Bionics make in fiscal 2025?
- Beta Bionics reported revenue of $100.3m for fiscal 2025, compared with $65.1m in fiscal 2024.
- How much has the revenue of Beta Bionics grown?
- Between fiscal 2023 and fiscal 2025 it went from $12.0m to $100.3m: 735.8% more, an average growth of 189.1% a year.
- What was the best year for revenue at Beta Bionics?
- Of its last 3 fiscal years, fiscal 2025, with $100.3m.
- Where does Beta Bionics rank in its sector by revenue?
- It ranks 286th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Beta Bionics come from?
- From the annual report (Form 10-K) that Beta Bionics files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Beta Bionics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023. More on Beta Bionics: the Beta Bionics page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.